Clinical Biosensors: Emerging Technologies, Applications, and Translational Horizons
Biosensors · 12.11.2026 · 16 (11) · 649
DOI: 10.3390/bios16110649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 12.11.2026. Verfasst von Mengdie Xue und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Science and Technology Department, Henan AIMS Professional Development Fund, Zhengzhou Science and Technology Benefit-the-People Program.
Abstract (Originalsprache)
Biosensors have become indispensable tools in clinical diagnostics, transforming how diseases are detected, monitored, and managed. In this review, we survey six key emerging platform classes: engineered biorecognition biosensors (CRISPR-Cas, aptamer, molecularly imprinted polymers); electrochemical and electrical biosensors (graphene/MXene/quantum-dot nanomaterial transducers, field-effect, electrochemical impedance spectroscopy, photoelectrochemical sensing); optical and plasmonic biosensors (SPR, LSPR, SERS); lateral flow and paper-based assays; artificial intelligence-integrated smart diagnostics; and lab-on-chip microfluidic systems. For each, we analyze the recognition chemistry, transduction strategy, and reported clinical performance. We then map these technologies onto high-impact clinical domains: infectious disease, oncology, cardiovascular medicine, diabetes and metabolic monitoring, critical care and sepsis, and neurodegenerative disease—highlighting representative and quantitative performance metrics and explicitly distinguishing analytical performance from clinical validation status using a six-level validation framework. Finally, we discuss the translational barriers (reproducibility, matrix complexity, manufacturing scalability, regulatory pathways, and biocompatibility) and the opportunities that health-economic evidence for microfluidic platforms, AI integration, and wearable and implantable form factors offer for closing the gap between analytical performance demonstrated in laboratory settings and real-world clinical adoption.
Förderung
- Henan Science and Technology Department
- Henan AIMS Professional Development Fund
- Zhengzhou Science and Technology Benefit-the-People Program
Zitieren
APA
Xue, M., Fan, W., Zhou, L., & Yin, L. (2026). Clinical Biosensors: Emerging Technologies, Applications, and Translational Horizons. Biosensors, 16(11), 649. https://doi.org/10.3390/bios16110649
Vancouver
Xue M, Fan W, Zhou L, Yin L. Clinical Biosensors: Emerging Technologies, Applications, and Translational Horizons. Biosensors. 2026;16(11):649. doi:10.3390/bios16110649
BibTeX
@article{Xue2026,
author = {Xue, Mengdie and Fan, Weihua and Zhou, Lin and Yin, Lei},
title = {Clinical Biosensors: Emerging Technologies, Applications, and Translational Horizons},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {11},
pages = {649},
doi = {10.3390/bios16110649}
}
EUVIMED